Bullboard - Stock Discussion Forum Replimune Group Inc REPL

Healthcare Biotechnology

Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a... see more

Add To Watchlist

NDAQ:REPL - Post Discussion

Replimune Group Inc > REPL Price Target Alert: $17.00. Issued by H.C. Wainwright

View:

Post by whytestocks on Jun 07, 2024 1:00pm

REPL Price Target Alert: $17.00. Issued by H.C. Wainwright

Just In: $REPL REPL Price Target Alert: $17.00. Issued by H.C. Wainwright2024-06-07 07:00:05 ET Robert Burns from H.C. Wainwright issued a price target of $17.00 for REPL on 2024-06-07 06:07:00. The adjusted price target was set to $17.00. At the time of the announcement, REPL was trading at $7.11. The overall price target consensus is at $26...REPL - REPL Price Target Alert: $17.00. Issued by H.C. Wainwright